Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
369.93B
Market cap369.93B
Price-Earnings ratio
118.10
Price-Earnings ratio118.10
Dividend yield
2.27%
Dividend yield2.27%
Average volume
14.06M
Average volume14.06M
High today
$151.68
High today$151.68
Low today
$147.76
Low today$147.76
Open price
$150.18
Open price$150.18
Volume
9.86M
Volume9.86M
52 Week high
$156.92
52 Week high$156.92
52 Week low
$77.58
52 Week low$77.58

Stock Snapshot

Merck(MRK) stock is priced at $149.85, giving the company a market capitalization of 369.93B. It carries a P/E multiple of 118.10 and pays a dividend yield of 2.27%.

On 2026-09-01, Merck(MRK) stock moved within a range of $147.76 to $151.68. With shares now at $149.85, the stock is trading +1.4% above its intraday low and -1.2% below the session's peak.

Trading volume for Merck(MRK) stock has reached 9.86M, versus its average volume of 14.06M.

The stock's 52-week range extends from a low of $77.58 to a high of $156.92.

The stock's 52-week range extends from a low of $77.58 to a high of $156.92.

MRK News

Nasdaq 8h
Broker Darlings of the Dow: Merck Ranks As a Top 15 Analyst Pick

A study of analyst recommendations at the major brokerages shows that Merck & Co Inc (Symbol: MRK) is the #8 broker pick, on average, out of the 30 stocks makin...

Broker Darlings of the Dow: Merck Ranks As a Top 15 Analyst Pick
Zacks 8h
Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough - Zacks Investment Research

...

Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough - Zacks Investment Research
TipRanks 3d
Schwab US Dividend Equity ETF Sees Inflows Amid Healthcare Developments

Schwab US Dividend Equity ETF ( $SCHD ) has fallen by 0.88% in the past week. It has experienced a 5-day net inflow of $640.6 million. This is due, in part, to...

Analyst ratings

68%

of 31 ratings
Buy
67.7%
Hold
29%
Sell
3.2%

More MRK News

Nasdaq 4d
Warren Buffett Thinks Investors Are "Gambling" Right Now. Here are 2 Stocks That Should Be Safe Bets.

Key Points Johnson & Johnson has increased its dividend for 64 consecutive years. Merck has raised its dividend for 26 consecutive years. Both drug companies...

Warren Buffett Thinks Investors Are "Gambling" Right Now. Here are 2 Stocks That Should Be Safe Bets.
Simply Wall St 5d
Merck Hits A Key Melanoma Milestone, Is The Stock Fully Priced?

Merck (MRK) is back in focus after a Phase 3 study of intismeran autogene with Keytruda met its primary endpoints in melanoma, validating meaningful clinical be...

Merck Hits A Key Melanoma Milestone, Is The Stock Fully Priced?
Simply Wall St 7d
Why Merck Is Up 15.7% After Breakthrough Phase 3 mRNA Melanoma Therapy Data – And What’s Next

On 19 August 2026, Merck & Co. and Moderna reported that their individualized mRNA-based neoantigen therapy intismeran, combined with Keytruda, achieved positiv...

Why Merck Is Up 15.7% After Breakthrough Phase 3 mRNA Melanoma Therapy Data – And What’s Next

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.